Excision repair cross‐complementation group 1 protein expression predicts survival in patients with high‐grade, non‐metastatic osteosarcoma treated with neoadjuvant chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|67|3|338-347

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.67, Iss.3, 2015-09, pp. : 338-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 447-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi‐institutional study

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3844-3852

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity

By  

Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. : 107-117

Karger

Access to resources Recommend Favorite

Effects of Arsenic Trioxide on Minor Progressive High-Grade Osteosarcoma of the Extremities Metastatic to the Lung: Results of 39 Patients Treated in a Single Institution

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 610-628

Karger

Access to resources Recommend Favorite

Editorial Comment to p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 453-454

John Wiley & Sons Inc

Access to resources Recommend Favorite